Stock VOX VOXEL S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Voxel S.A.

Equities

VOX

PLVOXEL00014

Market Closed - Warsaw S.E.
Other stock markets
 11:55:41 2024-04-29 am EDT 		5-day change 1st Jan Change
92.2 PLN +1.99% Intraday chart for Voxel S.A. +1.54% +17.30%
Mar. 11 Amadeus IT Group Buys Voxel Media in EUR113 Million Deal MT
2023 Voxel S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

  • Overall, the company has poor fundamentals for a medium to long-term investment strategy.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
VOXEL S.A. Stock Voxel S.A.
+17.30% 235M -
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.37% 8.25B
B+
RADNET, INC. Stock RadNet, Inc.
+40.93% 3.58B
C+
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-35.59% 2.46B
B-
SYNLAB AG Stock SYNLAB AG
-7.88% 2.46B -
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.95% 2.38B
B-
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-5.93% 1.81B
C-
FLEURY S.A. Stock Fleury S.A.
-18.96% 1.55B
A-
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.35% 1.21B
C+
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+6.91% 1.11B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. VOX Stock
  4. Ratings Voxel S.A.